Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 22, 2021

SELL
$14.81 - $19.13 $14,810 - $19,130
-1,000 Closed
0 $0
Q4 2020

Feb 11, 2021

SELL
$10.14 - $15.19 $1,267 - $1,898
-125 Reduced 11.11%
1,000 $14,000
Q3 2020

Oct 28, 2020

BUY
$9.57 - $21.32 $1,196 - $2,665
125 Added 12.5%
1,125 $11,000
Q4 2019

Jan 24, 2020

BUY
$13.01 - $17.15 $13,010 - $17,150
1,000 New
1,000 $14,000

Others Institutions Holding OMER

About OMEROS CORP


  • Ticker OMER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,730,000
  • Market Cap $762M
  • Description
  • Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...
More about OMER
Track This Portfolio

Track Valeo Financial Advisors, LLC Portfolio

Follow Valeo Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Valeo Financial Advisors, LLC with notifications on news.